Mr. James (jay) Bradner
Board of Directors
Novartis
France
Biography
Mr. James (Jay) Bradner, M.D. is President of the Novartis Institutes for BioMedical Research (NIBR), Member of the Executive Committee of Novartis Inc. March 1, 2016. Prior to joining Novartis, Dr. Bradner was on the faculty of Harvard Medical School in the Department of Medical Oncology at the Dana-Farber Cancer Institute in the United States. He was also associate director of the Center for the Science of Therapeutics at the Broad Institute of MIT and Harvard. Dr. Bradner is a co-founder of five biotechnology companies and has co-authored more than 150 scientific publications and 30 US patent application. Mr. James (Jay) Bradner, M.D. is President of the Novartis Institutes for BioMedical Research (NIBR), Member of the Executive Committee of Novartis Inc. March 1, 2016. Prior to joining Novartis, Dr. Bradner was on the faculty of Harvard Medical School in the Department of Medical Oncology at the Dana-Farber Cancer Institute in the United States. He was also associate director of the Center for the Science of Therapeutics at the Broad Institute of MIT and Harvard. Dr. Bradner is a co-founder of five biotechnology companies and has co-authored more than 150 scientific publications and 30 US patent application.
Research Interest
Finance Market
